What is the current stock price of BioCorRx Inc. (BICX)?

As of the latest market data, BioCorRx Inc. (BICX) is trading at $0.26. The stock has seen a loss of -34.75% today.

Does BioCorRx Inc. (BICX) pay a dividend?

Based on current data, BioCorRx Inc. does not have a confirmed active dividend policy.

What is the market cap of BioCorRx Inc.?

The current market capitalization of BioCorRx Inc. (BICX) is approximately unavailable.

BICX

BioCorRx Inc.·Healthcare

0.26

34.750%(−0.14)

Market Closed

Last Updated: — ET

52W L: $0.2052W H: $0.50

BICX NEWS

defenseworld.net

Mar 27

Head-To-Head Analysis: Biocorrx (OTCMKTS:BICX) and IceCure Medical (NASDAQ:ICCM)

IceCure Medical (NASDAQ: ICCM - Get Free Report) and Biocorrx (OTCMKTS:BICX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Risk and Volatility IceCure Medical has a beta

defenseworld.net

Mar 23

GoodRx (NASDAQ:GDRX) versus Biocorrx (OTCMKTS:BICX) Critical Comparison

Biocorrx (OTCMKTS:BICX - Get Free Report) and GoodRx (NASDAQ: GDRX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability. Profitability This table compares Biocorrx and GoodRx's net margins,

defenseworld.net

Mar 12

Biocorrx (OTCMKTS:BICX) Stock Price Crosses Above 50 Day Moving Average – Here’s What Happened

Biocorrx Inc. (OTCMKTS:BICX - Get Free Report)'s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.32 and traded as high as $0.3995. Biocorrx shares last traded at $0.3995, with a volume of 4,789 shares. Biocorrx Stock Performance The company's 50

Company Profile

BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. It distributes and licenses BioCorRx recovery program, a non-addictive and medication-assisted treatment program that includes a counseling program coupled with its proprietary naltrexone implant; and distributes UnCraveRx weight loss management program, a medically assisted weight management program to reduce food cravings combined with on-demand virtual lifestyle support, fitness, and nutrition. The company is also developing BICX101, an injectable naltrexone product; and BICX104, an implantable naltrexone implant for the treatment of opioid addiction and alcoholism. It distributes its program to healthcare providers, independent licensed clinics, and licensed healthcare professionals. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. BioCorRx Inc. is based in Anaheim, California.

Sector

Healthcare

Industry

Medical - Care Facilities

Employees

IPO Date

2010-08-31

Beta

0.30

Websitewww.biocorrx.com↗